Medinex OTX

SGD 0.22 +2.27% +0.01 Updated 18 Nov 2026, 17:16 SGT

Company profile

The business, the people and the ownership behind Medinex.

Business overview

About the company

Medinex Limited is a Singapore-based medical support services provider. It helps clinics with setup, licensing, accounting, tax, human resources and corporate secretarial services, and procures medical and pharmaceutical products. It also provides business support services to clients outside healthcare. Its medical services segment was discontinued with effect from 31 March 2026 following the disposal of Express Medical.

Issuer source ↗ Reviewed 2026-10-17 · Source dated 2026-07-09. PDF p. 3, 75, 110

Listed security

Company & listing

Full Company Name
MEDINEX LIMITED
Trading Currency
SGD
Website
www.medinex.com.sg
Listing
Listed on 7 December 2018 on CATALIST
ISIN Code
SGXE82839874

Board & management

Leadership

Five issuer Board directors, four other key management people and two joint secretaries, with Chai Yee Hoi counted once for his combined roles. No current CFO or extra operating-director Board seat inferred. Annual appointment dates and later AGM re-elections are separately dated.

Tan Lee Meng

Non-Executive Chairman

Appointed 22 May 2017. Member of Audit, Remuneration and Nominating Committees.

Jessie Low Mui Choo

Executive Director and Chief Executive Officer

Appointed 1 June 2017; overall management, strategy and business development.

Lim Tai Toon

Lead Independent Non-Executive Director

Appointed 14 November 2018. Audit Chairman; Remuneration and Nominating member.

Ye Binlin

Independent Non-Executive Director

Appointed 1 September 2020. Remuneration Chairman; Audit and Nominating member.

Venkata Subramanian S/O Sreenivasan

Independent Non-Executive Director

Appointed 23 August 2021. Nominating Chairman; Audit and Remuneration member.

Lee Kim Hung

Chief Operating Officer

Group long-term strategy and Nex Healthcare operations; not an issuer Board member.

Low Siam Kiang

Financial Controller

Re-appointed Financial Controller from 16 January 2024; former Chief Integration Officer from June 2022. Group finance and accounting. No current CFO title is invented.

Chai Yee Hoi

Chief Tax Officer; Joint Company Secretary

Business support tax advisory and AccTax director. Also one of two joint Company Secretaries; one person with combined roles, not issuer Board.

Valerie Low

Chief Business Development Officer

Also Managing Director of Ark Leadership & Learning and director of MDX Advisory and Carlin. Register name Low Mui Keow, Valerie (Lu Meijiao, Valerie); not an issuer Board member.

Lin Moi Heyang

Joint Company Secretary

Other joint Company Secretary; not an issuer Board member.

24 July 2026 AGM re-elections

Tan Lee Meng and Jessie Low Mui Choo re-elected; Forvis Mazars LLP re-appointed

All resolutions passed. Re-election is not a new appointment. AGM minutes list Wong Zi En as the attending audit partner; annual report is signed by engagement partner Lok Yung Hui. As reported at 2026-07-24

Roles listed in Annual Report 2026; current appointments are not independently verified.

Holdings

Ownership

Twenty registered accounts, ten substantial-holder rows, eleven register contexts and three separately dated interest changes. Annual footnote account-name discrepancy retained explicitly. Direct and deemed interests overlap. Jessie August acquisition updates her interest without rewriting June register. Readable Form1/Form3 companions are used, not XFA placeholders.

Jessie Low Mui Choo

0.29%Total interest

Direct 28,543,140 shares21.21%deemed 390,000 shares
Register 15 June 2026. Direct and deemed shares can overlap with other holders; never sum as independent ownership. As reported at 2026-06-15

Tan Lee Meng

6.45%Total interest

Direct 12,122,040 shares9.01%deemed 8,674,460 shares
Register 15 June 2026. Direct and deemed shares can overlap with other holders; never sum as independent ownership. As reported at 2026-06-15

HC Surgical Specialists Limited (“HCSS”)

9.26%Total interest

Direct 30,071,050 shares22.35%deemed 12,460,110 shares
Register 15 June 2026. Direct and deemed shares can overlap with other holders; never sum as independent ownership. As reported at 2026-06-15

Shinex Capital Pte. Ltd. (“Shinex Capital”)

9.26%Total interest

Direct 8,674,460 shares6.45%deemed 12,460,110 shares
Register 15 June 2026. Direct and deemed shares can overlap with other holders; never sum as independent ownership. As reported at 2026-06-15

HSN Healthcare Pte. Ltd. (“HSN Healthcare”)

Direct 12,460,110 shares; 9.26%; deemed – shares; –%

Register 15 June 2026. Direct and deemed shares can overlap with other holders; never sum as independent ownership. As reported at 2026-06-15

Dr. Heah Sieu Min

22.35%Total interest

Direct – shares–%deemed 30,071,050 shares
Register 15 June 2026. Direct and deemed shares can overlap with other holders; never sum as independent ownership. As reported at 2026-06-15

Dr. Chia Kok Hoong

22.35%Total interest

Direct – shares–%deemed 30,071,050 shares
Register 15 June 2026. Direct and deemed shares can overlap with other holders; never sum as independent ownership. As reported at 2026-06-15

Shine Medi-Capital Pte. Ltd.

6.45%Total interest

Direct – shares–%deemed 8,674,460 shares
Register 15 June 2026. Direct and deemed shares can overlap with other holders; never sum as independent ownership. As reported at 2026-06-15

Sia Ling Sing

6.45%Total interest

Direct – shares–%deemed 8,674,460 shares
Register 15 June 2026. Direct and deemed shares can overlap with other holders; never sum as independent ownership. As reported at 2026-06-15

Lim Ewe Ghee

6.45%Total interest

Direct – shares–%deemed 8,674,460 shares
Register 15 June 2026. Direct and deemed shares can overlap with other holders; never sum as independent ownership. As reported at 2026-06-15

Issued ordinary shares

134,543,843 shares

One vote per ordinary share; not the EPS weighted denominator. As reported at 2026-06-15

Treasury shares and subsidiary holdings

No treasury shares or subsidiary holdings

Express register statement as at 15 June 2026. As reported at 2026-06-15

Registered shareholders

236 holders

Distribution bands sum to the stated total. As reported at 2026-06-15

Distribution of shares

60 / 12,600 / 341,900 / 23,359,040 / 110,830,243 shares

1 / 23 / 53 / 144 / 15 holders respectively; exact denominator 134,543,843 shares. As reported at 2026-06-15

Twenty largest registered accounts

85.53%Total interest

115,086,803 shares
All twenty names and printed aggregate retained. Printed 85.53% equals the sum of rounded account percentages; the exact aggregate ratio rounds to 85.54%. Source percentage is preserved, not silently changed. As reported at 2026-06-15

Public float

Approximately 28.29%

Issuer-stated float; unknown nominee ownership is not inferred. As reported at 2026-06-15

Jessie Low Mui Choo nominee-account source discrepancy

28,543,140 direct shares; 390,000 deemed shares

Footnote (1) says 13,269,000 in Hong Leong Finance Nominees and 15,274,140 in Citibank Nominees. The preceding top20 instead lists 15,274,140 under Jessie herself and only 1,059,400 under Citibank. Preserve both original disclosures; no reassignment or correction inferred. As reported at 2026-06-15

Jessie Low Mui Choo spouse deemed interest

390,000 shares

Spouse Karunanithi S/O Letchumanan; overlaps the deemed interest already shown, not extra shares. As reported at 2026-06-15

Shine Medi-Capital and Shinex ownership chain

66.67% / 37.50% / 25.00% / 37.50%

Tan Lee Meng holds 66.67% Shine Medi-Capital, which holds 37.50% Shinex; Sia Ling Sing holds 25.00% and Lim Ewe Ghee 37.50% Shinex. Their deemed issuer shares overlap Shinex direct 8,674,460. As reported at 2026-06-15

HCSS and Shinex interests through HSN Healthcare

40.0% / 40.0%

Both hold 40.0% of HSN Healthcare; the same 12,460,110 issuer shares are attributed as deemed interests, not extra shares. As reported at 2026-06-15

Dr Heah Sieu Min and Dr Chia Kok Hoong interests through HCSS

41.72% / 22.66%

Approximate respective HCSS ownership. Each deemed issuer holding is the same 30,071,050 directly held by HCSS. As reported at 2026-06-15

Jessie Low Mui Choo — 5 August 2026 acquisition

21.8%Total interest

400,000 sharesS$92,000direct 28,943,140 shares21.51%deemed 390,000 shares0.29%total 29,333,140 shares
Separate post-register update, not substituted into the 15 June register. Readable Form1 companion provides actual disclosure; one-page XFA placeholder contains no readable values. As reported at 2026-08-05

Tan Lee Meng — 21 May 2026 deemed-interest change

15.46%Total interest

12,122,040 direct shares9.01%8,674,460 deemed shares6.45%total 20,796,500 shares
Acquired 66.67% in Shine Medi-Capital, which owns 37.50% Shinex. Issuer direct shares unchanged; this event precedes and explains the June register. Not an issuer share purchase of 8,674,460 shares. As reported at 2026-05-21

Tan Tin Nam — 21 May 2026 cessation

680,500 direct shares; 0.51%; deemed 0 shares; total 680,500 shares

Disposed his 66.67% Shine Medi-Capital holding and ceased 8,674,460 deemed issuer shares. Retained direct issuer shares; cessation of substantial status is not sale of all issuer shares. Distinct from director Tan Lee Meng. As reported at 2026-05-21

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 20 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-06-15 · PDF p. 95

Registered holderInterestShares / unitsSource
HC SURGICAL SPECIALISTS LIMITED30,071,050 shares; 22.35%PDF p. 952026-06-15
JESSIE LOW MUI CHOO15,274,140 shares; 11.35%PDF p. 952026-06-15
HONG LEONG FINANCE NOMINEES PTE LTD13,269,000 shares; 9.86%PDF p. 952026-06-15
HSN HEALTHCARE PTE. LTD.12,460,110 shares; 9.26%PDF p. 952026-06-15
BNP PARIBAS NOMINEES SINGAPORE PTE LTD12,122,040 shares; 9.01%PDF p. 952026-06-15
SHINEX CAPITAL PTE LTD8,674,460 shares; 6.45%PDF p. 952026-06-15
DBS NOMINEES PTE LTD6,808,287 shares; 5.06%PDF p. 952026-06-15
LEO TING PING RONALD2,000,000 shares; 1.49%PDF p. 952026-06-15
CHAI YEE HOI1,698,120 shares; 1.26%PDF p. 952026-06-15
KOH SEW LEAN1,610,000 shares; 1.20%PDF p. 952026-06-15
CGS INTERNATIONAL SECURITIES SINGAPORE PTE. LTD.1,600,000 shares; 1.19%PDF p. 952026-06-15
NG HOCK KON1,500,000 shares; 1.11%PDF p. 952026-06-15
LOW MUI KEOW, VALERIE (LU MEIJIAO, VALERIE)1,483,636 shares; 1.10%PDF p. 952026-06-15
NOVUS CORPORATE FINANCE PTE. LTD.1,200,000 shares; 0.89%PDF p. 952026-06-15
CITIBANK NOMINEES SINGAPORE PTE LTD1,059,400 shares; 0.79%PDF p. 952026-06-15
TEOU KEM ENG @TEOU KIM ENG900,000 shares; 0.67%PDF p. 952026-06-15
JITENDRA KUMAR SEN866,500 shares; 0.64%PDF p. 952026-06-15
PHILLIP SECURITIES PTE LTD861,000 shares; 0.64%PDF p. 952026-06-15
WAYNE KOO KIM HENG (WAYNE QIU JINXING)829,060 shares; 0.62%PDF p. 952026-06-15
JEREMY LEE SHENG POH800,000 shares; 0.59%PDF p. 952026-06-15

Group structure

Main operating subsidiaries

Nine current wholly owned directly held subsidiaries; Express Medical disposed 31 March 2026; former Sen Med struck off per dated official announcement, with contradictory annual Note15 retained explicitly. Two explicitly classified joint ventures at effective 20%, including Malaysian entity held through HEPL. MDX Professional Services formerly Medinex Professional Services, not two companies. Carlin settlement separates new issuance, existing treasury transfer and cash repurchase cost.

CompanyMarketOwnership interest
Medinex Corporate Services Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Business support services
Medinex Healthcare Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Medical support services
Nex Healthcare Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Medical support services and pharmaceutical services
Acctax Management Consultancy Private LimitedNote15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Business support services
MDX Professional Services Pte. Ltd. (f.k.a. Medinex Professional Services Pte. Ltd.)Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Business support services
Ark Leadership & Learning Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Human resources consultancy and learning development services
MDX Advisory Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Business support services
Medinex Corporate Services Sdn. Bhd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 Malaysia; Group ownership 2026/2025 100/100%; NCI –/–%; Shared service centre
Carlin Management Services Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained.PDF p. 742026-03-31 Singapore; Group ownership 2026/2025 100/100%; NCI –/–%; Business support services
Express Medical Pte. Ltd.Note15; held directly by Company. Group ownership and NCI 2026/2025 are separately retained. Former 55%-owned subsidiary disposed on 31 March 2026; no longer held at year-end. S$100,000 cash consideration, gain S$17,180 and net cash inflow S$78,211. Not a current subsidiary.PDF p. 742026-03-31 Singapore; Group ownership 2026/2025 –/55%; NCI –/45%; Operation of medical clinic and the provision of medical services
Sen Med Holdings Pte. Ltd.Official 30 May 2025 Rule706A announcement and current group chart agree on 29 May 2025. Current Note15 p75 instead says fully dissolved 29 May 2026 and describes voluntary liquidation. Preserve this source date/procedure discrepancy; not current subsidiary.PDF p. 12025-05-29 Former 55%-owned subsidiary; struck off 29 May 2025
Carlin Management Services Pte. Ltd. — deferred consideration settled100% acquisition completed 1 April 2022. Deferred S$600,000 consideration settled on 11 December 2025: 2,666,667 shares in total, including existing treasury shares. New shares expected listed 15 December, distinct from allotment date. Treasury transfer announcement values transferred shares at issue price S$183,150; cash repurchase cost S$185,078 is a different measure.PDF p. 12025-12-11 1,852,667 new shares; 814,000 treasury shares; S$0.225 per share
Healthcare Essentials Pte. Ltd. (“HEPL”)Note16 explicit joint-control conclusion; held by Company directly. Effective 20% is stated, not multiplied again. Malaysian entity new in FY2026, prior-year dash is retained.PDF p. 772026-03-31 Singapore; effective Group equity 2026/2025 20/20%; Distribution of medical consumables
Healthcare Essentials Sdn. Bhd. (“HESB”)Note16 explicit joint-control conclusion; held by Healthcare Essentials Pte. Ltd.. Effective 20% is stated, not multiplied again. Malaysian entity new in FY2026, prior-year dash is retained.PDF p. 772026-03-31 Malaysia; effective Group equity 2026/2025 20/–%; Distribution of medical consumables

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
Lin Moi Heyang Company Secretary Key management PDF p. 99

Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

ItemValuePeriod / scopeSource
Number of issued and paid-up shares 134,543,843 shares Company · As at 2026-06-15 PDF p. 95
Class of shares Ordinary shares Company · As at 2026-06-15 PDF p. 95
Voting rights One vote per share Company · As at 2026-06-15 PDF p. 95

Treasury shares

ItemValuePeriod / scopeSource
Treasury shares or subsidiary holdings There are no treasury shares or subsidiary holdings held as at 15 June 2026. Company · As at 2026-06-15 PDF p. 95

Shareholding distribution

ItemValuePeriod / scopeSource
TOTAL 236 shareholders Company, all size bands · As at 2026-06-15 PDF p. 95
1 - 99 1 shareholder; 0.42%; 60 shares; 0.00% Company, size of shareholdings 1 - 99 · As at 2026-06-15 PDF p. 95
100 - 1,000 23 shareholders; 9.74%; 12,600 shares; 0.01% Company, size of shareholdings 100 - 1,000 · As at 2026-06-15 PDF p. 95
1,001 - 10,000 53 shareholders; 22.46%; 341,900 shares; 0.25% Company, size of shareholdings 1,001 - 10,000 · As at 2026-06-15 PDF p. 95
10,001 - 1,000,000 144 shareholders; 61.02%; 23,359,040 shares; 17.36% Company, size of shareholdings 10,001 - 1,000,000 · As at 2026-06-15 PDF p. 95
1,000,001 and above 15 shareholders; 6.36%; 110,830,243 shares; 82.38% Company, size of shareholdings 1,000,001 and above · As at 2026-06-15 PDF p. 95

Free float

ItemValuePeriod / scopeSource
SHAREHOLDING HELD IN HANDS OF PUBLIC approximately 28.29% of the issued ordinary shares of the Company is held by the public Company · As at 2026-06-15 PDF p. 96
SHAREHOLDING HELD IN HANDS OF PUBLIC Rule 723 of the Listing Manual Section B: Rules of the Catalist is complied with. Company · As at 2026-06-15 PDF p. 96

Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
Interested Person Transactions The Company did not enter into any interested person transactions with a value of S$100,000 or more in FY2026. Company, FY2026 PDF p. 43
Service rendered fee 21,584 $ Group 2026 (with related parties*; entities where a director has beneficial interests); 2025 comparative 28,279 PDF p. 86
Management fee income 4,000,000 $ Company 2026, with subsidiaries; 2025 comparative 3,800,000; Group columns – PDF p. 86

Contingent liabilities

ItemValuePeriod / scopeSource
Financial guarantee $5,000,000 Company, corporate guarantees to banks for banking facilities of certain subsidiaries, 31 March 2026 (2025: $5,000,000) · As at 2026-03-31 PDF p. 86

Director remuneration

ItemValuePeriod / scopeSource
Ms. Jessie Low Mui Choo 339 S$’000 FY2026 total, S$’000, Executive Director/CEO PDF p. 38
- directors’ fees 106,250 $ Group, directors of the Company, 2026 and 2025 (both 106,250) PDF p. 86
aggregate total remuneration for the top four (4) key management personnel approximately S$791,000 FY2026, top four key management personnel (not Directors or CEO) PDF p. 38

Employees

ItemValuePeriod / scopeSource
Workforce Diversity 65 employees Group, as of 31 March 2026 · As at 2026-03-31 PDF p. 19

Outlook

ItemValuePeriod / scopeSource
LOOKING AHEAD We remain confident that these initiatives Chairman and CEO message, FY2026 PDF p. 5

Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.

Source: Annual Report 2026 ↗

Corporate information

Registration & contacts

Incorporated In
SINGAPORE
Incorporated On
12 Jan 2009
Email
[email protected]
Telephone
+65 66046330
Fax
+65 66046334
Registered Office
51, Goldhill Plaza, #22-03
Singapore 308900
Secretary
Chai Yee Hoi
Lin Moi Heyang
Registrar / Transfer Agent
TRICOR BARBINDER SHARE REGISTRATION SERVICES
Registrar Address
9 Raffles Place, Republic Plaza Tower I #26-01, Singapore 048619
Auditors
FORVIS MAZARS LLP
Other Stock Exchange Listings
*SINGAPORE EXCHANGE (CATALIST)
Country
SINGAPORE
Security Type
stocks